Found 1077 matching trials
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
PHASE3RATIONALE: Providing information that is tailored to answer patients' quest...
Location
Barbara Ann Karmanos Cancer Institute
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
PHASE2This is a prospective, multi-center, single arm study assessing the efficac...
Location
Henan Cancer Hospital
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
PHASE2This research study is studying the combination of anakinra and axicabtagen...
Location
Massachusetts General Hospital
Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors
PHASE1This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Location
Medical University of Innsbruck, Department for Internal Medicine I
Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
PHASE2This trial that is investigating a medication called duvelisib in combinati...
Location
Dana Farber Cancer Institute
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
PHASE3The purpose of this study is to compare a standard chemotherapy regimen of ...
Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimenInduction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimenInduction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimenInduction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimenInduction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimenConsolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimenMaintenance (intensive & non-intensive pathways) - lenalidomide maintenanceMaintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenanceHigh dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Allo HSCT Using RIC for Hematological Diseases
PHASE2This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Location
Masonic Cancer Center at University of Minnesota
Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia
PHASE4The goal of this clinical trial is to compare a short course of antibiotics...
Location
University Hospitals Leuven
Resiliency in Older Adults Undergoing Bone Marrow Transplant
N/AThe objective of this research is to measure certain indicators of resilien...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GKL-006Allo Injection in Patients With Advanced Solid Tumors
PHASE1This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinet...
Location
Cancer Hospital Chinese Academy of Medical Sciences